RNF182 and neoplasm: In conclusion, this work defines a novel tumor‐suppressive E3 ubiquitin ligase RNF182 which induces ubiquitination and degradation of p65 and consequently suppresses the transcription of PDL1, therefore, alleviating immunosuppression and cancer development.